Cleared Special

K130576 - CELSITE IMPLANTABLE ACCESS PORT SYSTEMS

K130576 is an FDA 510(k) clearance for CELSITE IMPLANTABLE ACCESS PORT SYSTEMS, manufactured by B. Braun Interventional Systems, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Special 510(k) pathway after a 28-day FDA review.

K130576 · B. Braun Interventional Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
28d
Days
Class 2
Risk

K130576 is an FDA 510(k) clearance for the CELSITE IMPLANTABLE ACCESS PORT SYSTEMS. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by B. Braun Interventional Systems, Inc. (Minneapolis, US). The FDA issued a Cleared decision on April 2, 2013 after a review of 28 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all B. Braun Interventional Systems, Inc. devices

FDA 510(k) Submission Details - K130576

510(k) Number K130576 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2013
Decision Date April 02, 2013
Days to Decision 28 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 129d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 195
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K130576.
5F DIGNITY CT TITANIUM PORT
K130923 · Medical Components, Inc. · Jul 2013
LPP (LOW PROFILE PORT)
K122402 · Pfm Medical, Inc. · Jul 2013
NMI PORT
K122767 · Navilyst Medical, Inc. · Apr 2013
POWERPORT CLEARVUE SLIM IMPLANTABLE PORT
K122899 · C.R. Bard, Inc. · Nov 2012
DIGNITY POWER INJECTABLE TITANIUM PORT
K120281 · Medical Components, Inc. · Sep 2012
NORFOLK MEDICAL-SPORTPORT-FAMILY OF PORTS
K112713 · Norfolk Medical Products, Inc. · Oct 2011